“…The strains belonging to BEC and its subtypes were resistant to most of the antimicrobials tested, except vancomycin and one or two other drugs, and showed homogeneous resistance to methicillin (since they all grew confluently on 25 µg/mL methicillin plates). The BEC strain is endemic in Brazilian hospitals, and its predominance among HA-MRSA has been reported since 1992, when it was first described in the country (5,6,12). This clone has also been isolated in other South American countries, in Europe and in Asia (1,3), demonstrating a superior ability for worldwide dissemination.…”